FcγR and EGFR polymorphisms as predictive markers of cetuximab efficacy in metastatic colorectal cancer.
Inoue Y, Hazama S, Iwamoto S, Miyake Y, Matsuda C, Tsunedomi R, Okayama N, Hinoda Y, Yamasaki T, Suehiro Y, Yoshino S, Sakamoto J, Mishima H, Oka M.
Inoue Y, et al. Among authors: oka m.
Mol Diagn Ther. 2014 Oct;18(5):541-8. doi: 10.1007/s40291-014-0103-6.
Mol Diagn Ther. 2014.
PMID: 24828248